Aptose Announces $4.43M Registered Direct Offering Of 3.855M Shares Of Common Stock At A Price Of $1.15/Share, Priced At-the-Market Under Nasdaq Rules
Portfolio Pulse from Benzinga Newsdesk
Aptose Biosciences Inc. (NASDAQ: APTO) announced a $4.43M registered direct offering of 3.855M shares at $1.15 per share. The offering includes unregistered series A and B warrants. The transaction is expected to close around June 3, 2024.
May 31, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Aptose Biosciences announced a $4.43M registered direct offering of 3.855M shares at $1.15 per share, including unregistered series A and B warrants. The offering is expected to close around June 3, 2024.
The issuance of new shares typically dilutes existing shareholders' equity, which can lead to a short-term decrease in stock price. The inclusion of warrants adds potential future dilution.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100